Skip to main content

CERTAINTY by Certara

Join our client summit to hear the latest innovations and opportunities to achieve better certainty to your drug development lifecycle.

Learn More

May 14-16, 2024, Philadelphia, PA

TECH-ENABLED SERVICES

Unmatched Experience and Expertise

Our drug-development consultation services reflect decades of experience from more than 650 healthcare and pharmaceutical professionals, as well as leading-edge technological solutions. This combination delivers the insights and knowledge to accelerate regulatory and commercial success while saving time and money.  Over the last decade, we have worked on more than 7,000 customer projects, across practice areas and drug development phases, leading to the extensive experience our customers highly value.

EXPLORE SERVICES

PROPRIETARY SOFTWARE

Leading the Industry in Drug Discovery and Development

Our quantitative approach to model-informed drug development offers a comprehensive view of the clinical and regulatory possibilities and challenges facing new therapies.  We derive significant insights that inform the development of our biosimulation software. These insights help us to anticipate and align our technology roadmap with our customers’ needs and priorities.  By providing the clearest picture of both opportunities and risks in the development lifecycle, we remove doubt and inspire confidence at key milestones during the process.

BROWSE SOFTWARE

Pinnacle 21 Clinical Data Management & Automation Suite

Pinnacle 21 Clinical Data Management & Automation Suite

Cloud suite of unified clinical data standardization, compliance and automation solutions to increase the speed and quality of clinical trial submission data.

Learn More
Phoenix Pharmacokinetic / Pharmacodynamic Platform

Phoenix Pharmacokinetic / Pharmacodynamic Platform

The global leader in software for preparing clinical trial data for regulatory submission.

Learn More
Simcyp Physiologically Based Pharmacokinetic (PBPK)

Simcyp Physiologically Based Pharmacokinetic (PBPK)

Simcyp PBPK models describe the behavior of drugs in different body tissues, with each tissue considered a physiological compartment.

Learn More
D360 Scientific Informatics Platform

D360 Scientific Informatics Platform

The platform, used by over 6,000 discovery scientists for small molecule and biologics research, provides self-service data access and integrated analysis solution.

Learn More
Certara.AI Platform

Certara.AI Platform

Certara.AI allows you to solve data silo problems while improving analytics capabilities that drive productivity and accelerated data discovery across life science R&D.

Learn More

SCIENTIFIC CONTENT

Transforming the Future of Drug Development

Our goal is to not only push the boundaries of what’s possible through medical therapies and devices, but also to challenge the thinking that drives regulatory science. We are committed to sharing our thought leaders’ insights and findings to question current approaches and envision what the future holds for biosimulation and public health.

VIEW MORE

01

The State of AI in In Silico Trials and Drug Development – The Practical Application of AI in QSP [APAC Webinar]

The proliferation of AI models and GPTs has revolutionized how the life sciences industry consumes information and uses it for accelerating and validating research. By leveraging GPTs, researchers can complete what would normally be weeks long literature review and data extraction tasks in a matter of minutes or hours. In this webinar, Certara&#8217;s experts will &hellip; <a href="https://www.certara.com/webinar/the-state-of-ai-in-in-silico-trials-and-drug-development-the-practical-application-of-ai-in-qsp-apac-webinar/">Continued</a>

Read More

01

BioIT World 2024

Read More

01

How to Avoid & Fix Common Mistakes in Regulatory Submissions

Please check your inbox for the white paper.

Read More

01

An Endogenous Biomarker for Predicting OATP1B DDIs

This blog reviews the role of the endogenous biomarker, CP-1, for assessing OATP1B transporter-mediated drug-drug interactions and their clinical implications.

Read More

Your Trusted Partner for Key Decision Points

“Certara’s contribution to the drug development program for Nurtec ODT was substantial. Their clinical pharmacology representative worked seamlessly with the Biohaven Development Team. Certara’s considerable expertise in clinical pharmacology and pharmacometrics and flawless execution supported Nurtec’s clinical development team and helped to prepare the clinical pharmacology NDA components.” Richard Bertz, PhDVice President, Clinical Pharmacology & Pharmacometrics

01

Case Study: Transforming Health Economics Communication for a Global Biopharmaceutical Company in Colombia
Read More

FEATURED CASE STUDIES

Success is Achieved Together

Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development.  In some cases, we can eliminate certain human trials completely.   More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services. See how we have helped companies like yours redefine what’s possible for safe and effective modern medicine.

Visit Case Studies